AJU IB Investment Co., Ltd. - Q1 2021 holdings

$265 Million is the total value of AJU IB Investment Co., Ltd.'s 11 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .

 Value Shares↓ Weighting
AVIR  ATEA PHARMACEUTICALS INC$126,546,000
+47.8%
2,049,3310.0%47.73%
+47.3%
SEER  SEER INC$53,340,000
-10.9%
1,066,3750.0%20.12%
-11.2%
APLS  APELLIS PHARMACEUTICALS INC$47,843,000
-25.0%
1,114,9620.0%18.05%
-25.2%
KYMR SellKYMERA THERAPEUTICS INC$24,834,000
-43.1%
639,059
-9.2%
9.37%
-43.3%
STRO  SUTRO BIOPHARMA$3,983,000
+4.8%
175,0000.0%1.50%
+4.5%
MTEM  MOLECULAR TEMPLATES INC$2,585,000
+34.4%
204,8090.0%0.98%
+33.9%
RAPT  RAPT THERAPEUTICS INC$2,409,000
+12.4%
108,5030.0%0.91%
+12.1%
CLSD  CLEARSIDE BIOMEDICAL INC$1,960,000
-9.8%
793,5550.0%0.74%
-10.2%
KZR  KEZAR LIFE SCIENCES INC$768,000
+14.1%
128,9160.0%0.29%
+13.7%
ALRN  AILERON THERAPEUTICS INC$740,000
+37.5%
517,5580.0%0.28%
+36.8%
 BELLICUM PHARMACEUTICALS INC$96,000
+5.5%
25,6510.0%0.04%
+5.9%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KYMERA THERAPEUTICS INC8Q3 202240.4%
SEER INC8Q3 202225.9%
RAPT THERAPEUTICS INC8Q3 20225.1%
SUTRO BIOPHARMA INC8Q3 20223.6%
ATEA PHARMACEUTICALS INC4Q3 202147.7%
APELLIS PHARMACEUTICALS INC4Q3 202138.8%
RALLYBIO CORP4Q3 202218.7%
XILIO THERAPEUTICS INC4Q3 202214.9%
CLEARSIDE BIOMEDICAL INC4Q3 20211.1%
MOLECULAR TEMPLATES INC4Q3 20211.0%

View AJU IB Investment Co., Ltd.'s complete holdings history.

Latest filings
TypeFiled
13F-HR/A2022-11-14
13F-HR2022-11-07
13F-HR2022-08-09
13F-HR2022-05-12
13F-HR2022-02-09
13F-HR2021-11-10
13F-HR2021-08-10
13F-HR2021-05-12
13F-HR2021-05-12
42017-11-13

View AJU IB Investment Co., Ltd.'s complete filings history.

Compare quarters

Export AJU IB Investment Co., Ltd.'s holdings